tag:blogger.com,1999:blog-7857054149675424609.post8455887712352199799..comments2024-02-24T08:58:08.581+00:00Comments on RNAi Therapeutics: ApoC III Confirmed as High Potential Gene Knockdown Target Dirk Hausseckerhttp://www.blogger.com/profile/18320439857875629714noreply@blogger.comBlogger2125tag:blogger.com,1999:blog-7857054149675424609.post-71034917347228698462013-06-24T15:29:47.632+00:002013-06-24T15:29:47.632+00:00ISIS has a head-start, but RNAi solutions which ar...ISIS has a head-start, but RNAi solutions which are likely to be much safer. If you look in the monoclonal arena, statins, or Macugen, it is often not about being the first to market. I obviously wrote the article to draw attention to the potential of RNAi Therapeutics and I would hope that others will make the same connection.Dirk Hausseckerhttps://www.blogger.com/profile/18320439857875629714noreply@blogger.comtag:blogger.com,1999:blog-7857054149675424609.post-43191521764381808162013-06-24T15:17:01.833+00:002013-06-24T15:17:01.833+00:00So this ISIS data is Negative for TKMR and ARWR? w...So this ISIS data is Negative for TKMR and ARWR? whats the impact Anonymousnoreply@blogger.com